K.
Conrad, R.-L. Humbel, M. Meurer, Y. Shoenfeld, E. M. Tan (Eds.)
Autoantigens and Autoantibodies: Diagnostic Tools and Clues
to Understanding Autoimmunity
-
Autoimmunity in liver diseases
-
M. P. Manns, A. Vogel, P. Obermayer-Straub: Hepatitis: A model to study virus-induced, drug-induced and idiopathic autoimmunity
-
P. Obermayer-Straub, J. Perheentupa, S. Braun, A. Kayser, Barut, S. Loges, A. Harms, G. Dalekos, C. P. Strassburg, M. P. Manns: Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
-
A. Vogel, H. Liermann, A. Harms, C. P. Strassburg, M. P. Manns, P. Obermayer-Straub: Autoimmune hepatitis and hepatitis as part of APECED do not overlap at the genetic level
-
Th. Simon, R. Kneusel, R.-L. Humbel, P. Schmit, C. Johanet, H. Haubruck, B. Liedvogel: Full-length formiminotransferase cyclodeaminase derived from baculovirus expression is a most suitable target for detecting anti-LC1 autoantibodies in AIH type II
-
T. Sugimura, P. Obermayer-Straub, A. Kayser, S. Braun, S. Loges, B. Lüttig, C. P. Strassburg, M. P. Manns: The major autoepitope of LKM1 autoantibodies in autoimmune hepatitis type 2 and in chronic hepatitis C is homologous to other cytochrome P450 autoantigens
-
M. Volkmann, L. Martin, A. Bäurle, H. Heid, C. Strassburg, C. Trautwein, W. Fiehn, M. P. Manns: SLA-P35: A cDNA encoding a gene product which specifically recognizes anti-SLA/LP sera from patients with autoimmune hepatitis
-
J. Herkel, B. Heidrich, I. Wies, A. W. Lohse: Autoantibodies to soluble liver antigen (SLA/LP) recognize at least three independent epitopes within the dominant antigenic region of the SLA/LP protein
-
M. Bäres, J. Herkel, I. Wies, S. Kanzler, A. J. Czaja , E.L. Cancado, M. Nishioka W. Schlumberger, W. Stöcker, A. W. Lohse: Establishment of a standardized SLA/LP immunoassay: SLA/LP positive autoimmune hepatitis occurs worldwide
-
E. Ballot, A. Bruneel, C. Johanet: Heterogeneity of anti-soluble liver antigen autoantibodies targets
-
T. Scheper, W. Meyer, A. Lohse, W. Schlumberger, W. Stöcker: Recombinant SLA/LP increases the sensitivity of an anti-liver-antibody westernblot for the diagnosis of autoimmune hepatitis
-
P. Schmit, G. Gilson, R. L. Humbel: Evaluation of an automated enzyme inhibition assay for the detection of anti-mitochondrial M2 autoantibodies
-
C. Recktenwald, M. A. Zuber: Clinical correlation of antimitochondrial antibodies
-
Y.-Y. Wu, T.-C. Hsu, T.-C. Liu, T.-Y. Chen, G.J. Tsay: Autoantibody to dihydrolipoamide dehydrogenase (E3) in hepatitis C infection
-
R. L. Humbel, C. Johanet, F. Oksman, M. San Marco, A. Escande, N. Olsson and members of the Group for Study of Autoimmunity GEAI, C. Hentschel, W. Schössler: Frequency of anti-Sp100 antibodies in antinuclear positive sera
-
P. Schmit, R. L. Humbel, C. Hentschel, W. Schössler: Specificity of antinuclear envelope antibodies to glycoprotein GP210 and lamin-B-receptor
-
M. Boissan, E. Ballot, C. Johanet: Kinetics of anti-gp210 antibodies in primary biliary cirrhosis patients with ursodesoxycholic acid therapy
-
B. Terjung, U. Spengler, T. Sauerbruch, H. J. Worman: A 50 kD myeloid cell-specific, nuclear envelope protein is the predominant target antigen of atypical p-ANCA in autoimmune liver disorders
-
L. Meheus, K. De Bosschere, H. Pottel, I. Peene, F. Hulstaert, F. De Keyser, M. Manns: Nuclear autoantibody profile in patients with liver disorders
-
E. Ballot, O. Bandin, R. Poupon, C. Johanet: Pathogeny of the primary biliary cirrhosis: The participation of endotoxin
|
Pabst
Science Publishers |
 |